Bone Marrow Concentrate Injection Treatment Improves Short-term Outcomes in Symptomatic Hip Osteoarthritis Patients: A Pilot Study

BACKGROUND: Osteoarthritis (OA) is one of the leading causes of disability in the United States, the hip being the second most affected weightbearing joint. Autologous bone marrow concentrate (BMC) is a promising alternative therapy to conventional treatments, with the potential to mitigate inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitney, Kaitlyn E., Briggs, Karen K., Chamness, Carolyn, Bolia, Ioanna K., Huard, Johnny, Philippon, Marc J., Evans, Thos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731709/
https://www.ncbi.nlm.nih.gov/pubmed/33344667
http://dx.doi.org/10.1177/2325967120966162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731709/
https://www.ncbi.nlm.nih.gov/pubmed/33344667
http://dx.doi.org/10.1177/2325967120966162

Ejemplares similares